Production (Stage)
scPharmaceuticals Inc.
SCPH
$3.55
-$0.03-0.84%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -19.74M | -18.85M | -35.11M | -17.09M | -14.11M |
| Total Depreciation and Amortization | 63.00K | 61.00K | -16.00K | 52.00K | 51.00K |
| Total Amortization of Deferred Charges | -- | 0.00 | 4.49M | -- | -- |
| Total Other Non-Cash Items | 2.76M | 3.43M | 17.52M | 3.27M | -1.16M |
| Change in Net Operating Assets | -224.00K | 164.00K | -4.31M | -6.46M | -2.48M |
| Cash from Operations | -17.14M | -15.19M | -17.42M | -20.23M | -17.70M |
| Capital Expenditure | -- | -12.00K | -9.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 0.00 | 1.00K | 29.32M |
| Cash from Investing | -- | -12.00K | -9.00K | 1.00K | 29.32M |
| Total Debt Issued | -- | 0.00 | 46.77M | -- | -- |
| Total Debt Repaid | -- | 0.00 | -50.00M | -- | -- |
| Issuance of Common Stock | -- | 171.00K | 53.59M | 283.00K | 181.00K |
| Repurchase of Common Stock | -- | 0.00 | 0.00 | 0.00 | -166.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -972.00K | -802.00K | 20.05M | -- | -- |
| Cash from Financing | -972.00K | -631.00K | 70.41M | 283.00K | 15.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -18.11M | -15.83M | 52.98M | -19.94M | 11.63M |